Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.
Oncologist
; 28(8): 682-690, 2023 08 03.
Article
in En
| MEDLINE
| ID: mdl-36946994
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country: